[HTML][HTML] Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA. 5 Omicron variant in mice
…, D Lee, B Whitener, B Ying, K Wu, CY Liang… - Nature medicine, 2023 - nature.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
in the Omicron lineage has resulted in diminished Coronavirus Disease 2019 (COVID-19) …
in the Omicron lineage has resulted in diminished Coronavirus Disease 2019 (COVID-19) …
[PDF][PDF] Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice
B Ying, SM Scheaffer, B Whitener, CY Liang… - Cell, 2022 - cell.com
The large number of spike substitutions in Omicron lineage variants (BA.1, BA.1.1., and BA.2)
could jeopardize the efficacy of SARS-CoV-2 vaccines. We evaluated in mice the …
could jeopardize the efficacy of SARS-CoV-2 vaccines. We evaluated in mice the …
Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains
…, AO Hassan, S Shrihari, CY Liang… - Science translational …, 2021 - science.org
Although mRNA vaccines encoding the spike protein of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) prevent COVID-19, the emergence of new viral variants …
coronavirus 2 (SARS-CoV-2) prevent COVID-19, the emergence of new viral variants …
[HTML][HTML] Boosting with Omicron-matched or historical mRNA vaccines increases neutralizing antibody responses and protection against B. 1.1. 529 infection in mice
B Ying, SM Scheaffer, B Whitener, CY Liang… - BioRxiv, 2022 - ncbi.nlm.nih.gov
The B. 1.1. 529 Omicron variant jeopardizes vaccines designed with early pandemic spike
antigens. Here, we evaluated in mice the protective activity of the Moderna mRNA-1273 …
antigens. Here, we evaluated in mice the protective activity of the Moderna mRNA-1273 …
[HTML][HTML] Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection
…, WI Wong, YL Wang, MP Hsieh, C Lu, CY Liang… - Mucosal …, 2018 - Elsevier
Peptide-based T cell vaccines targeting the conserved epitopes of influenza virus can provide
cross-protection against distantly related strains, but they are generally not immunogenic. …
cross-protection against distantly related strains, but they are generally not immunogenic. …
[HTML][HTML] A bivalent ChAd nasal vaccine protects against SARS-CoV-2 BQ. 1.1 and XBB. 1.5 infection and disease in mice and hamsters
B Ying, TL Darling, P Desai, CY Liang, IP Dmitriev… - bioRxiv, 2023 - ncbi.nlm.nih.gov
We previously described a nasally delivered monovalent adenoviral-vectored SARS-CoV-2
vaccine (ChAd-SARS-CoV-2-S, targeting Wuhan-1 spike [S]; iNCOVACC®) that is currently …
vaccine (ChAd-SARS-CoV-2-S, targeting Wuhan-1 spike [S]; iNCOVACC®) that is currently …
[HTML][HTML] The p150 isoform of ADAR1 blocks sustained RLR signaling and apoptosis during influenza virus infection
OA Vogel, J Han, CY Liang, S Manicassamy… - PLoS …, 2020 - journals.plos.org
Signaling through retinoic acid inducible gene I (RIG-I) like receptors (RLRs) is tightly regulated,
with activation occurring upon sensing of viral nucleic acids, and suppression mediated …
with activation occurring upon sensing of viral nucleic acids, and suppression mediated …
[PDF][PDF] mRNA vaccine boosting enhances antibody responses against SARS-CoV-2 Omicron variant in individuals with antibody deficiency syndromes
O Zimmerman, AMA Doss, P Kaplonek, CY Liang… - Cell Reports …, 2022 - cell.com
Individuals with primary antibody deficiency (PAD) syndromes have poor humoral immune
responses requiring immunoglobulin replacement therapy. We followed individuals with PAD …
responses requiring immunoglobulin replacement therapy. We followed individuals with PAD …
[HTML][HTML] Host factor Rab11a is critical for efficient assembly of influenza A virus genomic segments
…, C Twigg, Y Zhang, S Manivasagam, CY Liang… - PLoS …, 2021 - journals.plos.org
It is well documented that influenza A viruses selectively package 8 distinct viral ribonucleoprotein
complexes (vRNPs) into each virion; however, the role of host factors in genome …
complexes (vRNPs) into each virion; however, the role of host factors in genome …
[HTML][HTML] Mucosal vaccine-induced cross-reactive CD8+ T cells protect against SARS-CoV-2 XBB.1.5 respiratory tract infection
B Ying, TL Darling, P Desai, CY Liang, IP Dmitriev… - Nature …, 2024 - nature.com
A nasally delivered chimpanzee adenoviral-vectored severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) vaccine (ChAd-SARS-CoV-2-S) is currently used in India (…
coronavirus 2 (SARS-CoV-2) vaccine (ChAd-SARS-CoV-2-S) is currently used in India (…